ArticleThe clinical respiratory journal2025
Risk Factor Assessment and Predictive Modeling for Ventilator-Associated Pneumonia: Design and Clinical Implementation of an Artificial Intelligence-Enhanced Early Detection Framework Using Multisource Data Analytics.
Article in The clinical respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVentilator-associated pneumonia (VAP) is associated with poor patient outcomes. Early identification of high-risk patients remains a major clinical challenge. We aimed to develop and validate a multimodal hybrid neural network (MM-HNN) for improved VAP prediction by integrating multisource data from a retrospective cohort.
methodsThis single-center, retrospective study analyzed data from 213 adult patients who received invasive mechanical ventilation for >48 h. The MM-HNN incorporated three data types: 1) computed tomography (CT) features quantifying consolidation volume through three-dimensional residual neural network-50; 2) dynamic ventilator parameters including fraction of inspired oxygen and positive end-expiratory pressure analyzed via long short-term memory networks; and 3) clinical predictors refined via least absolute shrinkage and selection operator regression to identify six key variables.
resultsThe model achieved an area under the curve of 0.86 (95% confidence interval: 0.80-0.91), outperforming the clinical pulmonary infection score (p = 0.021). SHapley Additive exPlanation analysis revealed Acute Physiology and Chronic Health Evaluation II score and CT consolidation volume as primary contributors. The system provided early warnings with 87.5% accuracy (median lead time: 1.5 days), which was associated with a significant increase in appropriate antibiotic use from 68.3% to 92.1% (p = 0.016).
conclusionThe MM-HNN demonstrates the feasibility of accurate, interpretable VAP risk prediction through multimodal data integration. This artificial intelligence framework provides a clinically actionable tool for dynamic risk assessment, enabling preemptive interventions and improved antibiotic stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.